Tuesday, 30 April 2019

Wheat Protein Market to Reflect a Holistic Expansion During the Forecast Period: Grand View Research Inc.


San Francisco 30 April 2019 The Report Wheat Protein Market Analysis By Product (Wheat Gluten, Wheat Protein Isolate, Textured, Hydrolyzed), By Concentration (75%, 80%, 95%), By Application (Dairy, Bakery, Supplements, Animal Feed), And Segment Forecasts, 2018 - 2025

The global wheat protein market is expected to reach USD 2.15 billion by 2025, according to a new report by Grand View Research, Inc. Globally increasing consumer preference for meat free diets and rising applications in end user industries has been major factors driving the market growth. In addition, growing incidences of lactose intolerance has led to the increased demand for the market.

Wheat proteins find wide applications in the food & beverages industry in various products including confectionary, bakery, dairy, nutritional supplements and sports foods. The rising growth in the food & beverages industry is expected to be the key driver for wheat protein market growth over the forecast period. The market is expected to witness substantial growth led by increasing applications in bakery and confectionary products owing to their bread making quality.
Wheat gluten were the largest product category in 2015 and is expected to maintain a comparatively low growth rate over the forecast period. Wheat protein isolate is expected to witness fastest growth over upcoming years.
Nutritional supplements are expected to observe the fastest growth over the next nine years with an estimated CAGR of around 5% from 2016 to 2025. Wheat protein acts as a vital nutritional supplement for health. It is a low calorie supplement and contains higher level of glutamine as compared to whey and casein. It also helps to manage cholesterol levels and cure cardiovascular diseases. Varied benefits enable wheat protein to be an essential part of a healthy diet. Thus, driving the consumer demand.
Wheat protein isolates are majorly adopted by bodybuilders and strength training athletes as it is a high nutritional content protein and is low in calorie. As the consumer awareness regarding healthy lifestyle is rising the adoption of healthy nutritional supplements is augmenting. Wheat protein is increasing adopted as a vital health supplement mostly by people who prefer vegan and vegetarian diet. Moreover, increasing incidences of lactose intolerance is further augmenting the demand of wheat protein in the global market as a nutritional supplement.
Access Research Report of Wheat Protein Market @ http://www.grandviewresearch.com/industry-analysis/wheat-protein-market

Further key findings from the report suggest:
·       The global wheat protein demand reached 679.7 kilo tons in 2015 and is expected to grow at a CAGR of 4.3% from 2016 to 2025
·       Wheat gluten emerged as the largest product segment in 2015 and is estimated to generate revenue over USD 840.1 million by 2025
·       Global wheat protein demand in dairy was 81.3 kilotons in 2015 and is anticipated to witness staggered growth over the next nine years
·       The U.S. wheat protein market in dairy was 19.6 kilo tons in 2015 and is estimated to reach a total volume of over 21.6 kilotons by 2025
·       The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies. The regional market is expected to grow at a CAGR of 4.8% from 2016 to 2025
·       Archer Daniels Midland (ADM), Agridient, MGP Ingredients, AB Amilina, Cargill Inc. and Manildra Group, are few of the key market players of the global wheat protein market
Grand View Research has segmented the global wheat protein market on the basis of product, protein concentration, application and region:
Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         Wheat Gluten
·         Wheat Protein Isolate
·         Textured Wheat Protein
·         Hydrolyzed wheat Protein
Protein Concentration Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         75% protein concentration
·         80% protein concentration
·         95% protein concentration
Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         Dairy
·         Bakery & Confectionery
·         Nutritional Supplements
·         Animal Feed
Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         North America
·         Europe
·         Asia Pacific
·         Central & South America
·         Middle East & Africa 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

DNA & Gene Chip Market to Grow At a Slow yet Steady CAGR of 11.4% from 2018 to 2025: Grand View Research Inc.


San Francisco 30 April 2019 The Report DNA and Gene Chip Market Analysis Report By Product (Consumables, Instrumentation), By Application (Cancer Diagnosis & Treatment, Drug Delivery, Genomics), By End Use, And Segment Forecasts, 2018 - 2025

The global DNA & gene chip market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., at an 11.4% CAGR during the forecast period. DNA and gene chips have gained much success in providing high throughput capabilities for comprehensive genome studies to enhance disease knowledge and target them. This technology has emerged as a valuable and promising solution across various aspects of disease management. These factors have been driving the market.

Conventional means of gene analysis allow investigation of relatively small amounts of genes at a time, which further emphasizes on the uptake of DNA microarray technology. DNA microarray technology allows concurrent analysis of very large numbers of nucleic acid fragments in a single experiment.
Continuous development of new tools to support and enhance reliability of DNA microarray technology is likely to drive this market at a significant pace in the foreseeable future. Furthermore, healthcare entities are engaged in exploiting novel solutions for enhancing and combining data generated from gene chip with data generated from high throughput technologies. Mutually beneficial partnerships between microarray developers and pharmaceutical/biopharmaceutical companies for acceleration of genomic and biomedical research activities is anticipated to spur market growth in the coming years.
Access Research Report of DNA & Gene Chip Market @ https://www.grandviewresearch.com/industry-analysis/dna-gene-chip-market

Further key findings from the report suggest:
·       Based on product, consumables dominated the market with the largest share. This is due to presence of large number of entities engaged in providing reagents and kits associated with the use of DNA chips
·       The cancer treatment and diagnosis segment accounts for a significant share in the market owing to rising inclination toward development of companion diagnostics and growing usage of DNA microarrays in cancer diagnosis and treatment
·       Implementation of gene chip for drug discovery is also expected to increase in the coming years owing to growing demand for personalized medicine
·       By end use, academic/government research institutes accounted for the largest share in 2017. Ongoing research projects on gene expression analysis in these institutes have attributed for the estimated share
·       In terms of region, North America dominated the market with by revenue. High penetration of major revenue generating companies in U.S. has contributed to its leading share
·       Asia Pacific is projected to witness the fastest year-on-year growth owing to rising healthcare spending in developing economies and increase in R&D investment
·       Some of the prominent market participants are Agilent Technologies; Thermo Fisher Scientific, Incorporated (Affymetrix, Inc.); Illumina, Inc.; Macrogen Inc.; and Arrayit Corporation. These players are engaged in mutual partnerships with research communities and other diagnostic firms for use of gene chips for targeting disease prognosis.
Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global DNA & gene chip market on the basis of application, product, end use, and region:
DNA & Gene Chip Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Cancer diagnosis and treatment
·         Gene expression
·         Genotyping
·         Genomics
·         Drug discovery
·         Agricultural biotechnology
·         Others
DNA & Gene Chip Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Consumables
·         Instrumentation
DNA & Gene Chip End-use Outlook (Revenue, USD Million, 2014 - 2025)
·         Academic & Government Research Institutes
·         Hospitals & Diagnostics Centers
·         Biotechnology & Pharmaceutical Companies
·         Others
DNA & Gene Chip Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
·         Europe
·         Asia Pacific
·         Latin America
·         Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Solid Oxide Fuel Cells Market Estimated to Experience a Hike in Growth by 2025: Grand View Research Inc.


San Francisco 30 April 2019 The Report Solid Oxide Fuel Cell (SOFC) Market Analysis By Application (Stationary, Transportation, Portable), By Region (North America, Europe, Asia Pacific, MEA, CSA), And Segment Forecasts, 2018 - 2025

The global solid oxide fuel cell market is expected to reach USD 1.42 billion by 2025, growing at a CAGR of 30%, according to a report by Grand View Research, Inc. Government funding is largely being replaced by corporate funding and in turn exhibited to display positive growth potential. There has been an increase of more than 44% of corporate funding from the period 2013 until 2016 hence displaying feasible commercialization prospect for the technology. 

The rising pressure among nations to reduce carbon emissions while strengthening energy security is another factor favoring the growth of the solid oxide fuel cell market. Due to its working characteristic, solid oxide fuel cell has an efficiency in the range of 50-60%. However, there are concerns among solid oxide fuel cell manufacturers to reduce the production cost to generate significant profit margin.
The soaring capital & operational costs and underutilization of various facilities for the development of solid oxide fuel cell electric vehicle market are likely to result in high investment risks. High capital costs are directly related to the compression and storage of hydrogen. Therefore, highly pressurized hydrogen storage requires costly compressors. This is likely to pose a threat to market participants.
The Asia Pacific region is expected to benefit due to favorable governmental regulations in countries such as Japan and South Korea. Fuel cell powered automobiles and residential projects receive government subsidies in the region. Big players in North America such as Walmart, Coca-Cola, Equinix, Apple, CenturyLink, AT&T, Verizon are actively investing in solid oxide fuel cell technology to reduce emissions and generate power for company operations.
Access Research Report of Solid Oxide Fuel Cells Market @ http://www.grandviewresearch.com/industry-analysis/solid-oxide-fuel-cells-market

Further key findings from the report suggest:
·       The global solid oxide fuel cell market demand is expected to exceed 1,773.3 MW by 2025, at a predicted CAGR of 40.4% from 2017 to 2025
·       The transportation application is expected to witness growth rate in terms of units sold whereas stationary applications is expected to have the highest growth rate in terms of revenue
·       Asia Pacific was the largest consumer of solid oxide fuel cell in 2016, in terms of units, closely followed by North America
·       The consumption of solid oxide fuel cell in Europe is expected to reach 112.6 MW by the end of 2025 due to the restructuring of infrastructure in Germany and France
·       Japan accounted for over 30% of the global solid oxide fuel cell demand in 2016 and is expected to maintain dominance over the forecast period
Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/renewable-energy
Grand View Research has segmented the global solid oxide fuel cell market on the basis of application and region:
Application Outlook (Volume, Units; Capacity, Kw; Revenue, USD Thousand; 2014 - 2025)
·         Stationary
o    Distributed Energy Generation
o    EPS/UPS
·         Transportation
·         Portable
Regional Outlook (Volume, Units; Capacity, Kw; Revenue, USD Thousand; 2014 - 2025)
·         North America
·         Europe
·         Asia Pacific
·         Central & South America
·         Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Psoriasis Drugs Market is Estimated to Register a Strong CAGR of 9.4% from 2016 to 2022: Grand View Research Inc.


San Francisco 30 April 2019 The Report Psoriasis Drugs Market Analysis Report by Therapeutic Class (Interleukin-inhibitors, Tumor Necrosis Factor-inhibitors), by Treatment (Topicals, Systemic, Biologics), and Segment Forecasts, 2016 – 2022”

The global psoriasis drugs market size is expected to be valued at USD 21.11 billion by 2022, as per a new report by Grand View Research, Inc., experiencing a CAGR of 9.4% during the forecast period. Rising disease awareness, increasing number of reimbursement strategies for biologics, and advanced diagnostic and technological tools are likely to increase the adoption of psoriasis therapeutics.

Additionally, expanding base of patients suffering from psoriasis is anticipated to fuel growth prospects. The exact causative factors for psoriasis are undetermined; however, certain genetic and environmental factors may trigger the disease onset. Most available treatments aim to decelerate disease progression by stopping hyperproliferation of keratinocyte.
Psoriasis can be classified into five types: plaque, guttate, inverse, pustular, and erythrodermic. The types vary in terms of site of disease and characterization of lesions. Erythrodermic psoriasis is the rarest and plaque psoriasis is the most prevalent type affecting patients all over the world.
Incidence rate of psoriasis has witnessed a gradual rise over the years across various geographical locations. This increase can be attributed to genetic and environmental triggers as well as lifestyle changes. Rise in prevalence rates could also be associated with declining response or developing resistance to therapies for disease control.
Access Research Report of Psoriasis Drugs Market @ https://www.grandviewresearch.com/industry-analysis/psoriasis-drugs-market

Further key findings from the report suggest:
·       Tumor Necrosis Factor-inhibitors dominated the market in 2016 owing to its higher usage by healthcare practitioners and easy availability
·        TNF-inhibitors are likely to lose market shares over the forecast period due to increasing preference for IL-inhibitor therapy to conventional TNF-inhibitors
·        Interleukin-inhibitors is expected to register a lucrative CAGR of over 21.0% during the forecast period owing to improved safety and efficacy profiles of Interleukin-inhibiting drugs
·       The U.S is the dominant region in the psoriasis market in terms of revenue in 2016 due to increasing number of patients seeking treatment and presence of well-established healthcare services
·       Japan is expected to be the fastest growing region during the same period due to growing awareness about the disease among the populace
·       Some of the key players in this industry are AbbVie Inc.; Amgen Inc.; Johnson & Johnson; Novartis AG; Eli Lilly & Company; AstraZeneca; Celgene Corporation; UCB; and Merck.
Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global psoriasis drugs market based on therapeutic class, treatment, and region:
Therapeutic Class Outlook (Revenue, USD Million, 2016 - 2022)
·         Tumor Necrosis Factor Inhibitor
·         Interleukin Inhibitors
·         Others
Treatment Outlook (Revenue, USD Million, 2016 - 2022)
·         Topicals
·         Systemic
·         Biologics
Regional Outlook (Revenue, USD Million, 2016 - 2022)
·         U.S.
·         U.K.
·         Germany
·         Spain
·         France
·         Italy
·         Japan
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...